Doxorubicin/gold-loaded core/shell nanoparticles for combination therapy to treat cancer through the enhanced tumor targeting
- 1 April 2016
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 228, 141-149
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Health and Welfare (1420390)
This publication has 34 references indexed in Scilit:
- Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival ratesActa Oncologica, 2013
- Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trialThe Lancet Oncology, 2013
- Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysisThe Lancet Oncology, 2013
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast CancerNew England Journal of Medicine, 2013
- Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancerBritish Journal of Cancer, 2012
- Gold nanoparticles as novel agents for cancer therapyBritish Journal of Radiology, 2012
- Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder CancerJournal of Clinical Oncology, 2011
- Radiotherapy enhancement with gold nanoparticlesJournal of Pharmacy and Pharmacology, 2008
- Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.Journal of Clinical Oncology, 1998